Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic

Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Stevens, Andrew J. [verfasserIn] Patel, Akshar V. [verfasserIn] Wilson, Seth [verfasserIn] Cvetanovich, Gregory L. [verfasserIn] Bishop, Julie Y. [verfasserIn] Rauck, Ryan C. [verfasserIn]

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2023

Schlagwörter:	Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program

Übergeordnetes Werk:	Enthalten in: Seminars in arthroplasty - Philadelphia, Pa. : Elsevier, 2003, 33, Seite 613-617
Übergeordnetes Werk:	volume:33 ; pages:613-617

DOI / URN:	10.1053/j.sart.2023.05.006

Katalog-ID:	ELV061537292

Internformat


LEADER	01000caa a22002652 4500
001	ELV061537292
003	DE-627
005	20231205153731.0
007	cr uuu---uuuuu
008	230811s2023 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1053/j.sart.2023.05.006 \|2 doi
035			\|a (DE-627)ELV061537292
035			\|a (ELSEVIER)S1045-4527(23)00078-0
040			\|a DE-627 \|b ger \|c DE-627 \|e rda
041			\|a eng
082	0	4	\|a 610 \|q VZ
084			\|a 44.83 \|2 bkl
100	1		\|a Stevens, Andrew J. \|e verfasserin \|0 (orcid)0000-0002-8647-1879 \|4 aut
245	1	0	\|a Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
264		1	\|c 2023
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
520			\|a Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.
650		4	\|a Arthroplasty
650		4	\|a Reverse total shoulder arthroplasty
650		4	\|a Postoperative outcomes
650		4	\|a COVID-19
650		4	\|a Physical therapy
650		4	\|a Home exercise program
700	1		\|a Patel, Akshar V. \|e verfasserin \|4 aut
700	1		\|a Wilson, Seth \|e verfasserin \|0 (orcid)0000-0002-3157-298X \|4 aut
700	1		\|a Cvetanovich, Gregory L. \|e verfasserin \|4 aut
700	1		\|a Bishop, Julie Y. \|e verfasserin \|4 aut
700	1		\|a Rauck, Ryan C. \|e verfasserin \|0 (orcid)0000-0002-2129-8649 \|4 aut
773	0	8	\|i Enthalten in \|t Seminars in arthroplasty \|d Philadelphia, Pa. : Elsevier, 2003 \|g 33, Seite 613-617 \|h Online-Ressource \|w (DE-627)521469325 \|w (DE-600)2260910-6 \|w (DE-576)336961561 \|x 1558-4437 \|7 nnns
773	1	8	\|g volume:33 \|g pages:613-617
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_40
912			\|a GBV_ILN_60
912			\|a GBV_ILN_62
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_73
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_100
912			\|a GBV_ILN_101
912			\|a GBV_ILN_105
912			\|a GBV_ILN_110
912			\|a GBV_ILN_151
912			\|a GBV_ILN_187
912			\|a GBV_ILN_213
912			\|a GBV_ILN_224
912			\|a GBV_ILN_230
912			\|a GBV_ILN_370
912			\|a GBV_ILN_602
912			\|a GBV_ILN_702
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2007
912			\|a GBV_ILN_2008
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2011
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2020
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2025
912			\|a GBV_ILN_2026
912			\|a GBV_ILN_2027
912			\|a GBV_ILN_2034
912			\|a GBV_ILN_2044
912			\|a GBV_ILN_2048
912			\|a GBV_ILN_2049
912			\|a GBV_ILN_2050
912			\|a GBV_ILN_2055
912			\|a GBV_ILN_2056
912			\|a GBV_ILN_2059
912			\|a GBV_ILN_2061
912			\|a GBV_ILN_2064
912			\|a GBV_ILN_2068
912			\|a GBV_ILN_2088
912			\|a GBV_ILN_2106
912			\|a GBV_ILN_2110
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2112
912			\|a GBV_ILN_2122
912			\|a GBV_ILN_2129
912			\|a GBV_ILN_2143
912			\|a GBV_ILN_2152
912			\|a GBV_ILN_2153
912			\|a GBV_ILN_2190
912			\|a GBV_ILN_2232
912			\|a GBV_ILN_2470
912			\|a GBV_ILN_2507
912			\|a GBV_ILN_4035
912			\|a GBV_ILN_4037
912			\|a GBV_ILN_4112
912			\|a GBV_ILN_4125
912			\|a GBV_ILN_4242
912			\|a GBV_ILN_4249
912			\|a GBV_ILN_4251
912			\|a GBV_ILN_4305
912			\|a GBV_ILN_4306
912			\|a GBV_ILN_4307
912			\|a GBV_ILN_4313
912			\|a GBV_ILN_4322
912			\|a GBV_ILN_4323
912			\|a GBV_ILN_4324
912			\|a GBV_ILN_4325
912			\|a GBV_ILN_4326
912			\|a GBV_ILN_4333
912			\|a GBV_ILN_4334
912			\|a GBV_ILN_4338
912			\|a GBV_ILN_4393
912			\|a GBV_ILN_4700
936	b	k	\|a 44.83 \|j Rheumatologie \|j Orthopädie \|q VZ
951			\|a AR
952			\|d 33 \|h 613-617

Indexfelder

author_variant	a j s aj ajs a v p av avp s w sw g l c gl glc j y b jy jyb r c r rc rcr
matchkey_str	article:15584437:2023----::ucmsfeesttlhudrrholsyeeoavreyfe
hierarchy_sort_str	2023
bklnumber	44.83
publishDate	2023
allfields	10.1053/j.sart.2023.05.006 doi (DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0 DE-627 ger DE-627 rda eng 610 VZ 44.83 bkl Stevens, Andrew J. verfasserin (orcid)0000-0002-8647-1879 aut Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic 2023 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program Patel, Akshar V. verfasserin aut Wilson, Seth verfasserin (orcid)0000-0002-3157-298X aut Cvetanovich, Gregory L. verfasserin aut Bishop, Julie Y. verfasserin aut Rauck, Ryan C. verfasserin (orcid)0000-0002-2129-8649 aut Enthalten in Seminars in arthroplasty Philadelphia, Pa. : Elsevier, 2003 33, Seite 613-617 Online-Ressource (DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561 1558-4437 nnns volume:33 pages:613-617 GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 44.83 Rheumatologie Orthopädie VZ AR 33 613-617
spelling	10.1053/j.sart.2023.05.006 doi (DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0 DE-627 ger DE-627 rda eng 610 VZ 44.83 bkl Stevens, Andrew J. verfasserin (orcid)0000-0002-8647-1879 aut Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic 2023 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program Patel, Akshar V. verfasserin aut Wilson, Seth verfasserin (orcid)0000-0002-3157-298X aut Cvetanovich, Gregory L. verfasserin aut Bishop, Julie Y. verfasserin aut Rauck, Ryan C. verfasserin (orcid)0000-0002-2129-8649 aut Enthalten in Seminars in arthroplasty Philadelphia, Pa. : Elsevier, 2003 33, Seite 613-617 Online-Ressource (DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561 1558-4437 nnns volume:33 pages:613-617 GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 44.83 Rheumatologie Orthopädie VZ AR 33 613-617
allfields_unstemmed	10.1053/j.sart.2023.05.006 doi (DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0 DE-627 ger DE-627 rda eng 610 VZ 44.83 bkl Stevens, Andrew J. verfasserin (orcid)0000-0002-8647-1879 aut Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic 2023 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program Patel, Akshar V. verfasserin aut Wilson, Seth verfasserin (orcid)0000-0002-3157-298X aut Cvetanovich, Gregory L. verfasserin aut Bishop, Julie Y. verfasserin aut Rauck, Ryan C. verfasserin (orcid)0000-0002-2129-8649 aut Enthalten in Seminars in arthroplasty Philadelphia, Pa. : Elsevier, 2003 33, Seite 613-617 Online-Ressource (DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561 1558-4437 nnns volume:33 pages:613-617 GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 44.83 Rheumatologie Orthopädie VZ AR 33 613-617
allfieldsGer	10.1053/j.sart.2023.05.006 doi (DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0 DE-627 ger DE-627 rda eng 610 VZ 44.83 bkl Stevens, Andrew J. verfasserin (orcid)0000-0002-8647-1879 aut Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic 2023 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program Patel, Akshar V. verfasserin aut Wilson, Seth verfasserin (orcid)0000-0002-3157-298X aut Cvetanovich, Gregory L. verfasserin aut Bishop, Julie Y. verfasserin aut Rauck, Ryan C. verfasserin (orcid)0000-0002-2129-8649 aut Enthalten in Seminars in arthroplasty Philadelphia, Pa. : Elsevier, 2003 33, Seite 613-617 Online-Ressource (DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561 1558-4437 nnns volume:33 pages:613-617 GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 44.83 Rheumatologie Orthopädie VZ AR 33 613-617
allfieldsSound	10.1053/j.sart.2023.05.006 doi (DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0 DE-627 ger DE-627 rda eng 610 VZ 44.83 bkl Stevens, Andrew J. verfasserin (orcid)0000-0002-8647-1879 aut Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic 2023 nicht spezifiziert zzz rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients. Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program Patel, Akshar V. verfasserin aut Wilson, Seth verfasserin (orcid)0000-0002-3157-298X aut Cvetanovich, Gregory L. verfasserin aut Bishop, Julie Y. verfasserin aut Rauck, Ryan C. verfasserin (orcid)0000-0002-2129-8649 aut Enthalten in Seminars in arthroplasty Philadelphia, Pa. : Elsevier, 2003 33, Seite 613-617 Online-Ressource (DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561 1558-4437 nnns volume:33 pages:613-617 GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700 44.83 Rheumatologie Orthopädie VZ AR 33 613-617
language	English
source	Enthalten in Seminars in arthroplasty 33, Seite 613-617 volume:33 pages:613-617
sourceStr	Enthalten in Seminars in arthroplasty 33, Seite 613-617 volume:33 pages:613-617
format_phy_str_mv	Article
bklname	Rheumatologie Orthopädie
institution	findex.gbv.de
topic_facet	Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program
dewey-raw	610
isfreeaccess_bool	false
container_title	Seminars in arthroplasty
authorswithroles_txt_mv	Stevens, Andrew J. @@aut@@ Patel, Akshar V. @@aut@@ Wilson, Seth @@aut@@ Cvetanovich, Gregory L. @@aut@@ Bishop, Julie Y. @@aut@@ Rauck, Ryan C. @@aut@@
publishDateDaySort_date	2023-01-01T00:00:00Z
hierarchy_top_id	521469325
dewey-sort	3610
id	ELV061537292
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV061537292</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231205153731.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230811s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.sart.2023.05.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV061537292</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1045-4527(23)00078-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.83</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stevens, Andrew J.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-8647-1879</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthroplasty</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reverse total shoulder arthroplasty</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Postoperative outcomes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COVID-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Physical therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Home exercise program</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patel, Akshar V.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilson, Seth</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3157-298X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cvetanovich, Gregory L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bishop, Julie Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rauck, Ryan C.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-2129-8649</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Seminars in arthroplasty</subfield><subfield code="d">Philadelphia, Pa. : Elsevier, 2003</subfield><subfield code="g">33, Seite 613-617</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)521469325</subfield><subfield code="w">(DE-600)2260910-6</subfield><subfield code="w">(DE-576)336961561</subfield><subfield code="x">1558-4437</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">pages:613-617</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.83</subfield><subfield code="j">Rheumatologie</subfield><subfield code="j">Orthopädie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="h">613-617</subfield></datafield></record></collection>
author	Stevens, Andrew J.
spellingShingle	Stevens, Andrew J. ddc 610 bkl 44.83 misc Arthroplasty misc Reverse total shoulder arthroplasty misc Postoperative outcomes misc COVID-19 misc Physical therapy misc Home exercise program Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
authorStr	Stevens, Andrew J.
ppnlink_with_tag_str_mv	@@773@@(DE-627)521469325
format	electronic Article
dewey-ones	610 - Medicine & health
delete_txt_mv	keep
author_role	aut aut aut aut aut aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
issn	1558-4437
topic_title	610 VZ 44.83 bkl Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic Arthroplasty Reverse total shoulder arthroplasty Postoperative outcomes COVID-19 Physical therapy Home exercise program
topic	ddc 610 bkl 44.83 misc Arthroplasty misc Reverse total shoulder arthroplasty misc Postoperative outcomes misc COVID-19 misc Physical therapy misc Home exercise program
topic_unstemmed	ddc 610 bkl 44.83 misc Arthroplasty misc Reverse total shoulder arthroplasty misc Postoperative outcomes misc COVID-19 misc Physical therapy misc Home exercise program
topic_browse	ddc 610 bkl 44.83 misc Arthroplasty misc Reverse total shoulder arthroplasty misc Postoperative outcomes misc COVID-19 misc Physical therapy misc Home exercise program
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Seminars in arthroplasty
hierarchy_parent_id	521469325
dewey-tens	610 - Medicine & health
hierarchy_top_title	Seminars in arthroplasty
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)521469325 (DE-600)2260910-6 (DE-576)336961561
title	Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
ctrlnum	(DE-627)ELV061537292 (ELSEVIER)S1045-4527(23)00078-0
title_full	Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
author_sort	Stevens, Andrew J.
journal	Seminars in arthroplasty
journalStr	Seminars in arthroplasty
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology
recordtype	marc
publishDateSort	2023
contenttype_str_mv	zzz
container_start_page	613
author_browse	Stevens, Andrew J. Patel, Akshar V. Wilson, Seth Cvetanovich, Gregory L. Bishop, Julie Y. Rauck, Ryan C.
container_volume	33
class	610 VZ 44.83 bkl
format_se	Elektronische Aufsätze
author-letter	Stevens, Andrew J.
doi_str_mv	10.1053/j.sart.2023.05.006
normlink	(ORCID)0000-0002-8647-1879 (ORCID)0000-0002-3157-298X (ORCID)0000-0002-2129-8649
normlink_prefix_str_mv	(orcid)0000-0002-8647-1879 (orcid)0000-0002-3157-298X (orcid)0000-0002-2129-8649
dewey-full	610
author2-role	verfasserin
title_sort	outcomes of reverse total shoulder arthroplasty were not adversely affected by the covid-19 pandemic
title_auth	Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
abstract	Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.
abstractGer	Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.
abstract_unstemmed	Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_101 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_187 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_370 GBV_ILN_602 GBV_ILN_702 GBV_ILN_2001 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2007 GBV_ILN_2008 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2020 GBV_ILN_2021 GBV_ILN_2025 GBV_ILN_2026 GBV_ILN_2027 GBV_ILN_2034 GBV_ILN_2044 GBV_ILN_2048 GBV_ILN_2049 GBV_ILN_2050 GBV_ILN_2055 GBV_ILN_2056 GBV_ILN_2059 GBV_ILN_2061 GBV_ILN_2064 GBV_ILN_2068 GBV_ILN_2088 GBV_ILN_2106 GBV_ILN_2110 GBV_ILN_2111 GBV_ILN_2112 GBV_ILN_2122 GBV_ILN_2129 GBV_ILN_2143 GBV_ILN_2152 GBV_ILN_2153 GBV_ILN_2190 GBV_ILN_2232 GBV_ILN_2470 GBV_ILN_2507 GBV_ILN_4035 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4242 GBV_ILN_4249 GBV_ILN_4251 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4326 GBV_ILN_4333 GBV_ILN_4334 GBV_ILN_4338 GBV_ILN_4393 GBV_ILN_4700
title_short	Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic
remote_bool	true
author2	Patel, Akshar V. Wilson, Seth Cvetanovich, Gregory L. Bishop, Julie Y. Rauck, Ryan C.
author2Str	Patel, Akshar V. Wilson, Seth Cvetanovich, Gregory L. Bishop, Julie Y. Rauck, Ryan C.
ppnlink	521469325
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1053/j.sart.2023.05.006
up_date	2024-07-06T17:46:45.887Z
_version_	1803852716064112640
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV061537292</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20231205153731.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230811s2023 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1053/j.sart.2023.05.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV061537292</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1045-4527(23)00078-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.83</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Stevens, Andrew J.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-8647-1879</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2023</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: The objective was to investigate outcomes in reverse total shoulder arthroplasty (RTSA) in patients affected by the COVID-19 pandemic shutdown. We hypothesized that patients undergoing RTSA in early 2020 would have decreased access to physical therapy (PT) and worse postoperative outcomes compared to historical controls.Materials and methods: Patients who received primary RTSA between 1/1/2020, and 3/17/2020, were included and patients who received primary RTSA between 1/1/2019, and 3/17/2019, were used as a control group. Retrospective chart review was performed, and patient-reported outcomes were recorded at an average of 2.69 ± 0.06 years and a minimum of 1 year postoperatively. Patient data were collected and statistically analyzed using the 2-sample t-test and chi-square test. The Mann-Whitney U test and Fisher’s exact test were used when appropriate.Results: Thirty eight patients in 2020 were included in this study and compared to 31 patients in 2019. RTSA performed in 2019 had improvements in forward elevation (FE) (95.7° ± 47.2° to 144.7° ± 17.2°, P < .001), but not in external rotation (ER) (32.5° ± 20.3° to 41.0° ± 13.3°, P = .15), or internal rotation (IR) (S1 to L5, P = .76). RTSA 2020 cases had improvements in FE (111.5° ± 40.3 to 132.8° ± 30.6, P = .016), but not ER (31.9° ± 18.2 to 35.7° ± 15.9, P = .36) or IR (S1 to L5, P = .13). Patients in 2019 (FE: 4 to 5-, P < .001; ER: 4+ to 5-, P = .003; IR: 5- to 5, P < .001) and 2020 (FE: 4 to 5-, P < .001; ER: 4+ to 5, P < .001; IR: 5- to 5, P = .02) both experienced improvements in strength. Patients in 2020 initiated PT later (2019: 39.3 ± 27.3 days, 2020: 57.1 ± 35.5 days, P = .028) and completed less PT sessions (2019: 20.7 ± 11.1, 2020: 12.9 ± 6.6, P < .001) than patients in 2019. In the 2020 cohort, 10.5% (4/38) did not complete any PT, 34.2% (13/38) reported a delay in initiating PT, and 47.4% (18/38) reported that their recovery was negatively affected by the COVID-19 pandemic. At final follow-up, patients in 2020 reported a mean single assessment numeric evaluation score of 73.6 ± 17.5 on their affected shoulder and a mean visual analog scale score of 1.68 ± 1.23.Discussion: Despite a delay in initiating PT and completing less PT overall, patients who received RTSA in 2020 experienced significant improvements in range of motion and strength at final follow-up and were comparable to the 2019 patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Arthroplasty</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Reverse total shoulder arthroplasty</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Postoperative outcomes</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">COVID-19</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Physical therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Home exercise program</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patel, Akshar V.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wilson, Seth</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-3157-298X</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cvetanovich, Gregory L.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bishop, Julie Y.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rauck, Ryan C.</subfield><subfield code="e">verfasserin</subfield><subfield code="0">(orcid)0000-0002-2129-8649</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Seminars in arthroplasty</subfield><subfield code="d">Philadelphia, Pa. : Elsevier, 2003</subfield><subfield code="g">33, Seite 613-617</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)521469325</subfield><subfield code="w">(DE-600)2260910-6</subfield><subfield code="w">(DE-576)336961561</subfield><subfield code="x">1558-4437</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:33</subfield><subfield code="g">pages:613-617</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_101</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_187</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_370</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_702</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2007</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2008</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2020</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2025</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2026</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2027</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2034</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2044</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2049</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2056</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2059</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2061</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2064</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2068</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2088</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2106</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2122</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2129</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2143</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2152</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2153</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2190</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2232</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2470</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2507</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4035</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4242</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4251</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4326</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4333</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4334</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4393</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.83</subfield><subfield code="j">Rheumatologie</subfield><subfield code="j">Orthopädie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">33</subfield><subfield code="h">613-617</subfield></datafield></record></collection>
score	7.4010315

Nicht das Richtige dabei?

Schreiben Sie uns!

Outcomes of reverse total shoulder arthroplasty were not adversely affected by the COVID-19 pandemic

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?